Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines

Clinical and Experimental Metastasis

Volumn 33, Issue 5, 2016, Pages 487-496

  Moon, YeonHee ^a   Kim, Donghwi ^b   Sohn, HongMoon ^b   Lim, Wonbong ^b  

^a Chodang University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Cancer stem cell; Carcinogenesis; CD133; Epithelial to mesenchymal transition

Indexed keywords

CD133 ANTIGEN; NERVE CELL ADHESION MOLECULE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UVOMORULIN; VIMENTIN; TUMOR MARKER;

ARTICLE; CARCINOGENESIS; CELL INVASION; CELL INVASION ASSAY; CELL MEMBRANE; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; CYTOSOL; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; METASTASIS; MOUTH SQUAMOUS CELL CARCINOMA; ORAL CANCER CELL LINE; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CANCER STEM CELL; CELL DIFFERENTIATION; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUTH TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

AC133 ANTIGEN; BIOMARKERS, TUMOR; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS;

EID: 84965017415     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-016-9793-y     Document Type: Article

References (34)

1. Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359(11):1143–1154
2. Jemal A et al (2008) Cancer statistics. CA Cancer J Clin 58(2):71–96
3. Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4(6):448–456
4. DiTroia JF (1972) Nodal metastases and prognosis in carcinoma of the oral cavity. Otolaryngol Clin N Am 5(2):333–342
5. Roepman P et al (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37(2):182–186
6. Noguti J et al (2012) Metastasis from oral cancer: an overview. Cancer Gen Proteomics 9(5):329–335
7. Hirshberg A et al (2008) Metastatic tumours to the oral cavity—pathogenesis and analysis of 673 cases. Oral Oncol 44(8):743–752
8. Ho CM et al (1992) Occult lymph node metastasis in small oral tongue cancers. Head Neck 14(5):359–363
9. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755–768
10. Tirino V et al (2008) Detection and characterization of CD133 + cancer stem cells in human solid tumours. PloS One 3(10):e3469
11. Liu S et al (2015) G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma. Oncotarget 6(9):6887–6901
12. Angelastro JM, Lame MW (2010) Overexpression of CD133 promotes drug resistance in C6 glioma cells. Mol Cancer Res MCR 8(8):1105–1115
13. Zhang Q et al (2010) A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett 289(2):151–160
14. Corbeil D et al (2000) The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 275(8):5512–5520
15. Hilbe W et al (2004) CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57(9):965–969
16. Hemmati HD et al (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100(25):15178–15183
17. Chu P et al (2009) Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int J Cancer 124(6):1312–1321
18. Chiou SH et al (2008) Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14(13):4085–4095
19. Carvalho AL et al (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114(5):806–816
20. Yang CC et al (2013) Membrane type 1 matrix metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells. BMC Cancer 13:171
21. Chen C et al (2011) Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PloS One 6(1):e16466
22. Micalizzi DS, Farabaugh SM, Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplas 15(2):117–134
23. Xu MH et al (2014) EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells. PloS One 9(2):e87893
24. Bernards R, Weinberg RA (2002) A progression puzzle. Nature 418:823
25. Kang HJ, Jang YJ (2012) Selective apoptotic effect of Zelkova serrata twig extract on mouth epidermoid carcinoma through p53 activation. Int J Or Sci 4(2):78–84
26. Lee EJ et al (2005) Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med 37(5):379–390
27. Pang LY et al (2012) Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition. Vet J 193(1):46–52
28. Zhou BB et al (2009) Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8(10):806–823
29. Uchida N et al (2000) Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97(26):14720–14725
30. Iannolo G et al (2008) Apoptosis in normal and cancer stem cells. Crit Rev Oncol Hematol 66(1):42–51
31. Mizrak D, Brittan M, Alison M (2008) CD133: molecule of the moment. J Pathol 214(1):3–9
32. Bourguignon LY et al (2012) Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem 287(39):32800–32824
33. Gangopadhyay S et al (2013) Breast cancer stem cells: a novel therapeutic target. Clin Breast Cancer 13(1):7–15
34. Mani SA et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704–715